𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Addendum: Sartan treatment during pregnancy

✍ Scribed by Sura Alwan; Janine E. Polifka; Jan M. Friedman

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
46 KB
Volume
73
Category
Article
ISSN
1542-0752

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of acute leukemia during pregn
Treatment of acute leukemia during pregnancy
✍ Peter C. Raich; Luis B. Curet πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 159 KB πŸ‘ 2 views
Deferoxamine treatment during pregnancy:
Deferoxamine treatment during pregnancy: Is it harmful?
✍ Singer, Sylvia Titi; Vichinsky, Elliott P. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 22 KB

The use of the iron chelator, Deferoxamine (DFO), in pregnant thalassemia women with iron overload has been generally avoided due to fear of its potential teratogenicity. We describe a case of a pregnant thalassemia major patient with iron overload, who received DFO throughout her second and third t

Angiotensin II receptor antagonist treat
Angiotensin II receptor antagonist treatment during pregnancy
✍ S. Alwan; J.E. Polifka; J.M. Friedman πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 1 views

## Abstract Angiotensin II (A‐II) is the main effector of the renin‐angiotensin system. A‐II functions by binding its type 1 (AT1) receptors to cause vasoconstriction and retention of sodium and fluid. Several AT1 receptor antagonistsβ€”a group of drugs collectively called β€œsartans”—have been markete